Search results for

Authorities are assessing the toll of historic floods that devastated parts of western Germany that killed more than 150 people. German Chancellor Merkel described the situation as "terrifying."

Rocky Mountain Spotted Fever is the deadliest tickborne disease in the U.S. Rates of the disease are especially high on some tribal lands, but public health efforts to limit deadly cases are working.

Using the phrase "comeback kid" helped Bill Clinton revive his campaign for the Democratic presidential nomination in the 1992 New Hampshire primary. Could Ron DeSantis revive that model?

For decades, Trump has been arguing that trade deficits are bad. BUT - should we be eliminating trade deficits at all? Economist and Harvard professor Jason Furman says no.

Parents are increasingly turning to weighted sleepwear to help lull their babies to sleep, but a growing number of doctors and safe sleep advocates warn it comes with risks that shouldn't be ignored.

Tomorrow morning the Supreme Court begins a three-may marathon of oral arguments challenging President Obama's landmark health care law, the Affordable Care Act. Weekends on All Things Considered guest host Laura Sullivan previews the arguments with NPR legal affairs correspondent Nina Totenberg. She also speaks to Mark Gross, owner of a professional line standing service, who is poised to have a lucrative week, and Jeff Rother of the National Coalition on Health Care walks us back through health reform's tempestuous path to the Supreme Court.

Health insurance is turning into a top-tier issue in this year's presidential campaign. We asked the presidential hopefuls about their own coverage — and that of their staffs. Not everyone was talking.

Truvada is a pill that's already used to treat people with HIV. A daily dose can also significantly reduce the risk of new infection. And a panel recommended the FDA approve an over-the-counter HIV test, OraQuick. Users could test and interpret their results at home in as little as 20 minutes.

Domestic movie ticket sales seem to have topped out. Now, cinema owners are trying to lure customers — and justify higher ticket prices — with innovations like panoramic screens and so-called 4-D.

For every dollar spent on lobbying for a 2004 corporate tax bill, companies benefited $220, a new study says. That's a return of 22,000 percent.